NRG EAY191-N4

Primary Category:

Treatment Protocols

Disease Category:

Endometrial, Endometrial Metastatic, GYN Other, Gynecologic, Ovarian, Ovarian Metastatic

Status:

Open

A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients with Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial

NCT#05554328

(See required screening study ECOG-ACRIN EAY191)